rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Paul Talmo

Chief Technology Officer

Company insider

Files Form 4 as: Chief Technology Officer, TELA Bio.

In numbers

Trades disclosed
28
Buys
1
Sells
0
Bought
$50K
Sold
$0
Companies
1
Companies where not an officer
0
First trade
23 Feb 2022
Last trade
23 Feb 2026
Last filed
24 Feb 2026

Companies traded

Where they are an officer
TELA TELA BioOfficer · Medical Devices · last 23 Feb 20261 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
23 Feb 2026filed 24 Feb 2026TELA TELA BioMedical DevicesSEC FORM 4 Code F$3,1114,061 at $0.766filing
23 Feb 2026filed 24 Feb 2026TELA TELA BioMedical DevicesSEC FORM 4 Code F$3,1274,061 at $0.77filing
21 Feb 2026filed 24 Feb 2026TELA TELA BioMedical DevicesSEC FORM 4 Code F$2,4283,385 at $0.7174filing
21 Feb 2026filed 24 Feb 2026TELA TELA BioMedical DevicesSEC FORM 4 Code F$2,4373,385 at $0.72filing
20 Feb 2026filed 24 Feb 2026TELA TELA BioMedical DevicesSEC FORM 4 Code A—57,000 at $0.00filing
20 Feb 2026filed 24 Feb 2026TELA TELA Biooption or derivative · Medical DevicesSEC FORM 4 Code A—85,000 at $0.00filing
20 Feb 2026filed 24 Feb 2026TELA TELA Biooption or derivative · Medical DevicesSEC FORM 4 Code A—85,000 at $0.00filing
20 Feb 2026filed 24 Feb 2026TELA TELA BioMedical DevicesSEC FORM 4 Code A—57,000 at $0.00filing
31 Mar 2025filed 2 Apr 2025TELA TELA BioMedical DevicesSEC FORM 4 Code F$232190 at $1.22filing
24 Feb 2025filed 25 Feb 2025TELA TELA BioMedical DevicesSEC FORM 4 Code F$2,7801,049 at $2.65filing
23 Feb 2025filed 25 Feb 2025TELA TELA BioMedical DevicesSEC FORM 4 Code F$11K4,061 at $2.72filing
21 Feb 2025filed 25 Feb 2025TELA TELA Biooption or derivative · Medical DevicesSEC FORM 4 Code A—56,100 at $0.00filing
21 Feb 2025filed 25 Feb 2025TELA TELA BioMedical DevicesSEC FORM 4 Code A—38,100 at $0.00filing
24 Oct 2024filed 24 Oct 2024TELA TELA BioMedical DevicesSEC FORM 4 Bought$50K22,222 at $2.25filing
31 Mar 2024filed 2 Apr 2024TELA TELA BioMedical DevicesSEC FORM 4 Code F$1,077190 at $5.67filing
24 Feb 2024filed 27 Feb 2024TELA TELA BioMedical DevicesSEC FORM 4 Code F$7,4161,049 at $7.07filing
23 Feb 2024filed 27 Feb 2024TELA TELA Biooption or derivative · Medical DevicesSEC FORM 4 Code A—24,400 at $0.00filing
23 Feb 2024filed 27 Feb 2024TELA TELA BioMedical DevicesSEC FORM 4 Code A—16,700 at $0.00filing
23 Feb 2024filed 27 Feb 2024TELA TELA BioMedical DevicesSEC FORM 4 Code F$18K2,577 at $7.07filing
31 Mar 2023filed 4 Apr 2023TELA TELA BioMedical DevicesSEC FORM 4 Code F$1,990187 at $10.64filing

News

TELA Bio (NASDAQ:TELA) versus Shoulder Innovations (NYSE:SI) Head to Head SurveyTELA · dailypolitical.com · 14 Oct 2026

0 headlines in the last 90 days name Paul Talmo; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

William J. PlovanicDirector · Director at TELA Bio, filing Form 4 there in the last year
Joseph H. CapperDirector · Director at TELA Bio, filing Form 4 there in the last year
Heather C. GetzChief Executive Officer · Chief Executive Officer at TELA Bio, filing Form 4 there in the last year
Paul ThomasDirector · Director at TELA Bio, filing Form 4 there in the last year
Guy P. NohraDirector · Director at TELA Bio, filing Form 4 there in the last year